دانلود مقاله ISI انگلیسی شماره 127477
ترجمه فارسی عنوان مقاله

اثرات وابسته به سن متیل فنیدیت حاد بر واکنش آمیگدال در بیماران مبتلا به نارسایی تحریک کننده با اختلال کمبود توجه / بیش فعالی

عنوان انگلیسی
Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder
کد مقاله سال انتشار تعداد صفحات مقاله انگلیسی
127477 2017 31 صفحه PDF
منبع

Publisher : Elsevier - Science Direct (الزویر - ساینس دایرکت)

Journal : Psychiatry Research: Neuroimaging, Volume 269, 30 November 2017, Pages 36-42

پیش نمایش مقاله
پیش نمایش مقاله  اثرات وابسته به سن متیل فنیدیت حاد بر واکنش آمیگدال در بیماران مبتلا به نارسایی تحریک کننده با اختلال کمبود توجه / بیش فعالی

چکیده انگلیسی

In the present study, we investigate whether methylphenidate (MPH) affects emotional processing and whether this effect is modulated by age. We measured amygdala reactivity with functional Magnetic Resonance Imaging (fMRI) during processing of angry and fearful facial expressions in male stimulant treatment-naive patients with ADHD (N = 35 boys; N = 46 men) and 23 healthy control subjects (N = 11 boys; N = 12 men). In ADHD patients, we also measured amygdala reactivity 90 min after an acute oral challenge with MPH (0.5 mg/kg). Mean amygdala reactivity was analyzed for all subjects using a repeated measures analysis of variance (ANOVA). Whole-brain maps were analyzed for the patients only. At baseline, we found a age*diagnosis effect approaching significance (p = 0.05) in the right amygdala due to lower reactivity in children with Attention Deficit/Hyperactivity Disorder (ADHD) vs. controls (−31%), but higher reactivity in adults with ADHD vs. controls (+31%). MPH significantly reduced right amygdala reactivity in all patients, resulting in further reductions in children. In the left amygdala, reduction of amygdala reactivity was confined to adult ADHD patients whereas there was no change in children with ADHD. MPH-induced decrease of amygdala reactivity in adults might be a promising avenue for managing emotional dysregulation when replicated for chronic MPH treatment.